Vivimed Labs Ltd.
BSE: 532660 | Sector: Health care |
NSE: VIVIMEDLAB | ISIN Code: INE526G01021 |
BSE 00:00 | 24 Jun | 10.70 |
0.97 (9.97%) |
OPEN
10.00 |
HIGH
10.70 |
LOW
9.95 |
NSE 00:00 | 24 Jun | 10.65 |
0.95 (9.79%) |
OPEN
10.00 |
HIGH
10.65 |
LOW
10.00 |
OPEN | 10.00 |
PREVIOUS CLOSE | 9.73 |
VOLUME | 180080 |
52-Week high | 28.90 |
52-Week low | 7.58 |
P/E | |
Mkt Cap.(Rs cr) | 89 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Vivimed Labs Ltd. (VIVIMEDLAB) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 218.37 | 210.05 | 276.61 | 251.81 | 261.39 |
Other Income | 1.26 | 6.07 | 6.53 | 8.53 | 1.93 |
Total Income | 219.63 | 216.12 | 283.14 | 260.34 | 263.32 |
Total Expenditure | 227.58 | 188.26 | 244.31 | 184.55 | 184.52 |
Operating Profit | -7.96 | 27.86 | 38.83 | 75.79 | 78.80 |
Interest | 39.53 | 41.49 | 43.00 | 52.40 | 51.80 |
Gross Profit | -47.48 | -13.63 | -4.17 | 23.39 | 27.00 |
Depreciation | 17.45 | 15.80 | 16.57 | 18.26 | 18.14 |
PBT | -64.93 | -29.42 | -20.74 | 5.14 | 8.85 |
Tax | 0.00 | -0.23 | 0.00 | 1.04 | 1.70 |
Net Profit/(Loss) | -67.75 | -29.19 | -19.17 | 6.19 | 9.87 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | -67.75 | -29.19 | -19.17 | 6.19 | 9.87 |
Equity Share Capital | 16.58 | 16.58 | 16.58 | 16.50 | 16.50 |
Reserves Excluding Revaluation Reserves | 440.69 | 507.88 | 537.31 | 556.12 | 550.90 |
EPS | |||||
Basic EPS | -8.17 | -3.52 | -2.31 | 0.75 | 1.20 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Vivimed Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices